LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us

Author: Bob Driscoll

10/06/2025

Drug Discovery Online: Answering The Call To Develop Novel Drugs For Rare DiseasesDrug Discovery Online:

Faced with a serious diagnosis or an unexpected hospitalization, patients and their families are often left feeling like they’ve been hit with a gut punch. This insecurity is compounded when...
READ THE ARTICLE
07/29/2025

LAMASSU PETS NAMES FORMER NOVARTIS, PIEDMONT ANIMAL HEALTH EXECUTIVE MICHAEL KELLY AS STRATEGIC ADVISOR

(DURHAM, NC) – Lamassu Pets, the veterinary division of Lamassu Biotech, has announced the appointment of veteran animal health industry executive Michael Kelly to its Advisory Board. Widely respected in the animal health pharmaceutical sector, Kelly brings more...
READ THE ARTICLE
06/26/2025

Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, and...
READ THE ARTICLE

Posts navigation

Older posts
Newer posts

Recent Posts

  • Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors
  • FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS
  • Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs
  • RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech
  • SA53 MDM2 Inhibitor: Lamassu Biotech Reports Significant Progress and Favorable Safety Profile in Phase 1/2a Clinical Trial

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • January 2026
  • November 2025
  • October 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies